These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14981231)

  • 1. Consensus development conference on antipsychotic drugs and obesity and diabetes.
    ; ; ;
    Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.
    Megna JL; Schwartz TL; Siddiqui UA; Herrera Rojas M
    Ann Clin Psychiatry; 2011 May; 23(2):131-40. PubMed ID: 21547274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific standards: critical comments on the pharmacoepidemiological study of second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia.
    Cohen D
    J Clin Psychopharmacol; 2008 Aug; 28(4):461-2; author reply 462-4. PubMed ID: 18626279
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic effects of treatment with atypical antipsychotics.
    Kane JM; Barrett EJ; Casey DE; Correll CU; Gelenberg AJ; Klein S; Newcomer JW
    J Clin Psychiatry; 2004 Nov; 65(11):1447-55. PubMed ID: 15554755
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetes in treatment with antipsychotic drugs: who is at risk]].
    Deuschle M
    MMW Fortschr Med; 2005 Dec; 147(51-52):34. PubMed ID: 16402705
    [No Abstract]   [Full Text] [Related]  

  • 6. Obesity, diabetes and hypertension associated with antipsychotic use in remitted schizophrenia.
    Saddichha S; Vishnuvardhan G; Akhtar S
    Int J Risk Saf Med; 2011; 23(3):181-5. PubMed ID: 22020398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review.
    Koponen H; Saari K; Savolainen M; Isohanni M
    Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic agents and cardiometabolic morbidity in youth.
    Kruszewski SP; Paczynski RP
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):394-5; author reply 395. PubMed ID: 19349574
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical antipsychotic drugs, diabetes and ethnicity.
    Ananth J; Kolli S; Gunatilake S; Brown S
    Expert Opin Drug Saf; 2005 Nov; 4(6):1111-24. PubMed ID: 16255668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement.
    Citrome L; Volavka J
    J Clin Psychiatry; 2005 Aug; 66(8):1073-4. PubMed ID: 16086627
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes prevalence estimates in schizophrenia and risk factor assessment.
    Argo T; Carnahan R; Barnett M; Holman TL; Perry PJ
    Ann Clin Psychiatry; 2011 May; 23(2):117-24. PubMed ID: 21547272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset diabetes mellitus associated with quetiapine.
    Procyshyn RM; Pande S; Tse G
    Can J Psychiatry; 2000 Sep; 45(7):668-9. PubMed ID: 11056833
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse effects of atypical antipsychotics.
    Wirshing DA
    J Clin Psychiatry; 2001; 62 Suppl 21():7-10. PubMed ID: 11584988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary care issues in patients with mental illness.
    Kiraly B; Gunning K; Leiser J
    Am Fam Physician; 2008 Aug; 78(3):355-62. PubMed ID: 18711951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
    Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
    Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
    Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weighing in: emergent diabetes mellitus and second-generation antipsychotics.
    Dufresne RL
    Ann Pharmacother; 2007 Oct; 41(10):1725-7. PubMed ID: 17785611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.